A56-20671-55498
2 vaccinations
4 coded responses
6 check-ins
4 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 498 / MI
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Dose 1 — Moderna
-
2021-04-07
Dose 2 — Janssen/Johnson & Johnson
-
2021-04-16
Registered in v-safe
-
2021-04-16
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-21
-
2021-04-28
Survey response — day 21, dose 2MedDRA: Arthralgia, Dry eye, Fatigue, Headache, Rhinorrhoea, Throat irritation, Vision blurred — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Joint pain, scratchy throat, runny nose, mild headache, tired all the time, dry eyes, vision slightly blurred at times, live in rural area, limited cell service, can receive tex but all incoming calls must be through our landline (b)(6)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Survey response — day 28, dose 2MedDRA: Arthralgia, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: More joint pain, vision more blurry at times, headaches, dry eyes at times then watering eyes at times. Loss of appetite. Extremely tired.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-21
Survey response — day 42, dose 2MedDRA: Arthralgia, Dry eye, Headache, Muscular weakness, Myalgia, Office visit — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Headache, joint pains and muscle weakness/pain. Dry eyes, · Healthcare visit (other): Personal Doctor Office VisitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-21
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-31
-
2021-05-31
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2021-07-07
Survey response — 3 months, dose 2MedDRA: Chills, Gastrointestinal pain, Headache, Hyperhidrosis, Pyrexia, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Fever, chills, sweating, headache, Intestinal pain. · Healthcare visit (other): MRI, intestinal checkMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-07
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Moderna | |
| 2 | 2021-04-07 | Janssen/Johnson & Johnson |
Call center
2 call center cases
1 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 8 — day 21, dose 2
Symptoms: Joint pain, scratchy throat, runny nose, mild headache, tired all the time, dry eyes, vision slightly blurred at times, live in rural area, limited cell service, can receive tex but all incoming calls must be through our landline (b)(6)
redacted (b)(6)
Release 8 — day 28, dose 2
Symptoms: More joint pain, vision more blurry at times, headaches, dry eyes at times then watering eyes at times. Loss of appetite. Extremely tired.
Release 8 — day 42, dose 2
Symptoms: Headache, joint pains and muscle weakness/pain. Dry eyes,
Healthcare visit (other): Personal Doctor Office Visit
Release 9 — 3 months, dose 2
Symptoms: Fever, chills, sweating, headache, Intestinal pain.
Healthcare visit (other): MRI, intestinal check
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Dry eye | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal pain | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hyperhidrosis | ✓ | ✓ | ✓ |
| SD | Muscular weakness | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Throat irritation | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release